周梅花 朱宇霞 李丽秋 钱洁 徐丽燕 万育春 陈军香



摘 要 目的:調查评价颛桥社区老年高血压患者接受不同干预方式的疾病直接成本效用。方法:采用方便抽样方法于2017年10月选取老年高血压合并症患者148例,其中颛桥社区卫生服务中心接受住院治疗干预的患者58例、颛桥敬老院接受巡回医疗干预的患者30例,颛桥各社区接受“1+1+1”组合签约门诊干预的患者60例(进一步细分为门诊高龄亚组与门诊低龄亚组)。计算三组患者于2016年5月1日—2018年4月30日2年时间内接受不同干预方式的疾病直接成本—效用。结果: 2年的抗高血压药物费用为门诊高龄组最高(2 679.91元),门诊低龄组最低(2 210.43元);单纯计算抗高血压药物治疗费用,每获得一个完整QALY的成本为住院组最高(2 521.22元), 门诊低龄组最低(1 627.50元);从总直接成本、自付总金额来看,总直接成本为住院组最高(179 143.29元),门诊低龄组最低(19 215.47元),三组患者每获得一个完整QALY的费用差异有统计学意义(P<0.001);自付总金额为住院组最高(63 574.97元),门诊低龄组最低(9 929.61元)。结论:“1+1+1”组合签约服务和巡回医疗等医疗模式的开展极大地减轻了老年高血压患者的疾病经济负担,具有现实意义。
关键词 “1+1+1”组合签约服务;住院治疗;巡回医疗;成本效用
中图分类号:R197.1 文献标志码:A 文章编号:1006-1533(2018)20-0006-04
Study of the direct cost utility of 3 intervention methods for elderly hypertensive patients in Zhuanqiao Community
ZHOU Meihua1, ZHU Yuxia2, LI Liqiu3, QIAN Jie2, XU Liyan2, WAN Yuchun4, CHEN Junxiang5(1. Department of Nursing of Zhuanqiao Community Health Service Center of Minhang District, Shanghai 201108, China; 2. Department of Pharmacy of Zhuanqiao Community Health Service Center of Minhang District, Shanghai 201108, China; 3. Department of Medical Administration of Zhuanqiao Community Health Service Center of Minhang District, Shanghai 201108, China; 4.Outpatient Department of General Practice of Zhuanqiao Community Health Service Center of Minhang District, Shanghai 201108, China; 5. Department of Hospital Administration of Zhuanqiao Community Health Service Center of Minhang District, Shanghai 201108, China)
ABSTRACT Objective: To investigate and evaluate the direct cost utility of different chronic diseases intervention methods for elderly patients with hypertension in Zhuanqiao Community. Methods: In October, 2017, 148 elderly patients with hypertension complication were selected by convenience sampling, among them, 58 cases of patients received hospitalization intervention in Zhuanqiao Community Health Service Center, 30 patients received itinerant medical intervention in the Nursing Home of Zhuanqiao, and 60 patients in Zhuanqiao Community received the “1+1+1” combined signing outpatient intervention(further subdivided into an outpatient senior subgroup and an outpatient junior subgroup). The direct cost utility of the patients in three groups receiving different interventions during the two years from May 1, 2016 to April 30, 2018 was calculated. Results: The cost of antihypertensive drugs for 2 years was the highest in the outpatient senior group(2 679.91 Yuan),and the lowest in the outpatient junior group(2 210.43 Yuan); the cost of antihypertensive medications was calculated simply and the cost of obtaining a complete QALY was the highest in the inpatient group(2 521.22 Yuan), and the lowest in the outpatient junior group(1 627.50 Yuan); in terms of total direct cost and total amount of self-payment, the total direct cost was the highest in the inpatient group(179 143.29 Yuan) and the lowest in the outpatient junior group(19 215.47 Yuan), and there was a statistically significant difference in the cost of obtaining a complete QALY between the three groups(P<0.001); the total amount of selfpayment was the highest in the inpatient group(63 574.97 Yuan), and the lowest in the outpatient junior group(9 929.61 Yuan). Conclusion: The “1+1+1” combined signing service and itinerant medical treatment modes have greatly reduced the economic burden of the elderly patients with hypertension, which is of practical significance.
KEY WORDS “1+1+1” combined signing service; inpatient treatment; itinerant medical treatment; cost utility
随着我国银发潮的来临,社会普遍面临老龄化和慢性病流行的巨大挑战。据老龄办数据统计,截至2017年年底,我国60岁及以上老年人口有2.41亿,占全国人口的17.3%[1],80岁以上高龄老人和失能老年人口数大幅增加,老年人面临着各种各样的疾病经济负担问题,为个人、家庭和社会带来巨大影响[2]。近年来我国医药卫生领域成本-效用分析的文獻逐渐增多,其中仅测算直接医疗成本的多达61.3%,测算了直接成本和间接成本的占38.7%,其中多数文献以质量调整生命年(QALY)作为效用指标[3]。……